Stifel Raises MBX Biosciences Price Target to $84 From $70
Stifel maintained its Buy rating on MBX Biosciences, according to the supplied ratings report.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Stifel maintained its Buy rating on MBX Biosciences, according to the supplied ratings report.